Anti-CD137 Cancer Immunotherapy Suppresses Tumor Growth-Letter.

Dharmadhikari, Bhushan; Zeng, Qun; Wu, Meihui; Schwarz, Herbert

Dharmadhikari, Bhushan; Zeng, Qun; Wu, Meihui; Schwarz, Herbert.

Afiliação

Dharmadhikari B; Department of Physiology and Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Zeng Q; Department of Physiology and Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Wu M; Department of Physiology and Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Schwarz H; Department of Physiology and Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. phssh@nus.edu.sg.

Cancer Res ; 78(6): 1571, 2018 03 15.

Article em En | MEDLINE | ID: mdl-29490949

Assuntos

Ligante 4-1BB; Neoplasias; Humanos; Imunoterapia; Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ligante 4-1BB / Neoplasias Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Singapura

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google